CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company
Q/C TECHNOLOGIES, INC.
Sign in to watch- Ticker
- QCLS
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 856-848-8698
- Business address
- 1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
- Former names
- Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale · Other events
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Other events
- S-3/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-K Report Annual Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
Page 18 of 31 · 604 filings